What Has Been the Growth of the Transcatheter Embolization And Occlusion Devices Market So Far?
The transcatheter embolization and occlusion devices market has seen considerable growth due to a variety of factors.
• The transcatheter embolization and occlusion devices market has grown rapidly in recent years. It will grow from $4.76 billion in 2024 to $5.28 billion in 2025, at a CAGR of 10.9%.
The growth can be linked to the growing patient population, the rise in minimally invasive vascular surgeries, increasing vascular diseases, chronic conditions, and the demand for effective treatments.
What Is the Forecasted Market Size and Growth Rate for The Transcatheter Embolization And Occlusion Devices Market Size In The Coming Years?
The transcatheter embolization and occlusion devices market is expected to maintain its strong growth trajectory in upcoming years.
• The transcatheter embolization and occlusion devices market is forecasted to grow to $7.87 billion by 2029, with a CAGR of 10.5%.
Growth factors include increased research and development, healthcare sector expansion, growing use of minimally invasive techniques, an aging population, and greater awareness. Trends include technological advancements, improvements in imaging, AI and machine learning integration, device design enhancements, and advances in delivery systems.
What Factors Are Driving Growth In The Transcatheter Embolization And Occlusion Devices Market?
The spike in preference for minimally invasive methods is anticipated to push forward the expansion of the transcatheter embolization and occlusion devices market. Minimally invasive surgeries are those that employ minor cuts or natural bodily apertures to navigate and treat internal organs or tissues, thereby causing less harm to the patient's body. Transcatheter embolization and occlusion devices are crucial to these minimally invasive methods, as they provide several advantages such as decreased invasiveness, decreased recovery period, targetted treatment, less discomfort, fewer risk of complications, and the possibility for outpatient procedures. For example, Intuitive Surgical Inc., a U.S. firm that specializes in minimally invasive care products, reported in January 2023 that roughly 1,875,000 surgical procedures were conducted with Vinci surgical systems in 2022, indicating an increase of about 18% compared to approximately 1,594,000 surgical procedures in 2021. Therefore, the uptick in the demand for minimally invasive techniques is proliferating the growth of the transcatheter embolization and occlusion devices market.
What Are The Main Segments Of The Global Transcatheter Embolization And Occlusion Devices Market?
The transcatheter embolization and occlusion devices market covered in this report is segmented –
1) By Type: Coil, Non-Coil
2) By Application: Peripheral Vascular Disease, Oncology, Neurology, Urology, Other Applications
3) By End User: Hospitals, Ambulatory Surgical Centers, Clinics, Other End Users
Subsegments:
1) By Coil: Bare Metal Coil, Surface Coated Coil, Detachable Coil
2) By Non-Coil: Gelatin Sponge, Liquid Embolic Agents, Spheres And Particles
Pre-Book The Transcatheter Embolization And Occlusion Devices Global Market Report 2025 Report For Swift Delivery And Comprehensive Insights:
Which Emerging Market Trends Are Altering The Transcatheter Embolization And Occlusion Devices Industry?
In the transcatheter embolization and occlusion devices market, top-tier corporations are concentrating their efforts on developing technically sophisticated products, featuring options like multi-catheter compatibility, to deliver enhanced services to their clientele and maintain a competitive market presence. Multi-catheter compatibility allows various catheter types to be used in interventional procedures, accords more flexibility and efficiency to healthcare providers in conducting transcatheter embolization and occlusion surgeries. For example, Boston Scientific, an American medical products manufacturer, was granted FDA clearance in April 2022 for its novel product, EMBOLD Fibered Detachable Coil, designed specifically for peripheral vascular embolization procedures and being a component of its interventional oncology range. This innovational device aims to restrict or lessen blood supply to particular vessels, treating conditions like bleeding, aneurysm, tumor reduction, and venous irregularities. The included multi-catheter capability and a nitinol delivery system to avoid twists, simplify the procedures, lower the possible complications and boost efficiency.
Who Are the Key Players In The Transcatheter Embolization And Occlusion Devices Market?
Major companies operating in the transcatheter embolization and occlusion devices market are:
• Pfizer Inc.
• Johnson & Johnson Services Inc.
• Abbott Laboratories
• Medtronic Inc.
• Stryker Corporation
• Boston Scientific Corporation
• Edwards Lifesciences Corporation
• Terumo Corporation
• Teleflex Incorporated
• Cook Medical
• Merit Medical Systems Inc.
• Penumbra Inc.
• AtriCure Inc.
• Nordion Inc.
• Sirtex Medical Limited
• Cordis Corporation
• OpSens Inc.
• pfm medical ag
• Micro Interventional Devices Inc.
• Acandis GmbH
• Metactive Medical Inc.
What Is The Most Dominant Region In The Transcatheter Embolization And Occlusion Devices Market?
North America was the largest region in the transcatheter embolization and occlusion devices market in 2024. The regions covered in the transcatheter embolization and occlusion devices market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East and Africa.
